McCleanH, RadcliffeK, SullivanAK. British Association for Sexual Health and HIV (BASHH). Statement on Partner Notification for Sexually Transmissible Infections. July 2012. See http://www.bashh.org/guidelines (last checked 18 December 2012)
2.
Health Protection Agency.Hepatitis C in the UK: 2011 Report.London: Health Protection Agency, 2011
3.
Health Protection Agency.Shooting Up: Infections Among Injecting Drug Users in the UK 2010 – An Update: November 2011.London: Health Protection Agency, 2011
4.
Department of HealthHepatitis C Action Plan for England.London: Department of Health, 2004
5.
National Institute for Health and Clinical Excellence.Peginterferon Alfa and Ribavirin for the Treatment of Mild Chronic Hepatitis C.London: National Institute for Health and Clinical Excellence, 2006
6.
HopeV, ParryJV, MaronguiA. Hepatitis C infection among recent initiates to injecting in England 2000-2008: is a national hepatitis C action plan making a difference?J Viral Hepat2012; 19: 55-64
7.
BASHH.United Kingdom Guideline on the Management of the Viral Hepatitides A, B and C 2008. See http://www.bashh.org/guidelines (last checked 4 June 2012)
TurnerJ, BansiL, GilsonR. The prevalence of hepatitis C virus infection in HIV-positive individuals in the UK – trends in HCV testing and the impact of HCV on HIV treatment outcomes.J Viral Hepat2010; 17: 569-77
10.
British HIV Association.British HIV Association Guidelines for the Management of Co-infection with HIV-1 and Hepatitis B or C Virus, 2010. See http://www.bhiva.org/HepBC2010.aspx (last checked 4 June 2012)
BrewerD, HaganH. Evaluation of a patient referral contact tracing programme for hepatitis B and C virus infection in drug injectors.Eurosurueillance2009; 14www.eurosurveillance.org
14.
CowanF, FrenchR, JohnsonA. The role and effectiveness of partner notification in STD control: a review.Genitourin Med1996; 72: 247-52
15.
JowettJ, AgarwalK, SmithB. Managing chronic hepatitis C acquired through intravenous drug use.Q J Med2001; 94: 153-8
MorrillJ, ShresthaM, GrantR. Barriers to the treatment of hepatitis CJ Gen Intern Med2005; 20: 754-8
18.
ParkesJ, RoderickP, Bennett-LloydB. Variation in Hepatitis C services may lead to inequity of healthcare provision: a survey of the organisation and delivery of services in the United Kingdom.BioMed Central2006; 6: 3. See http://www.biomedcentral.eom/1471-2458/6/3 (last checked 12 August 2011)
19.
TrelleS, ShangA, NarteyL. Review 3: Revised rapid review of evidence for the effectiveness of partner notification for sexually transmitted infections including HIV. See http://www.nice.org.uk/nicemedia/live/11377/43877/43877.pdf (last checked 4 June 2012)
20.
MatthewsC, CoetzeeN, ZwarensteinM. Strategies for partner notification for sexually transmitted diseases.Cochrane Database Syst Rev2007, Issue 4, Art. No.:CD002843. DOI.10.1002/14651858.CD002843
21.
TurnerK, AdamsE, GrantA. Costs and cost effectiveness of different strategies for Chlamydia screening and partner notification: an economic and mathematical modelling study.Br Med J2010; 341: c7250. doi:10.1136/bmj.c7250
22.
TobinKE, MuessigKE, LatkinCA. HIV seropositive drug users’ attitudes towards partner notification (PCRS): results from the SHIELD study in Baltimore, Maryland.Patient Educ Conns2007; 67: 137-42
23.
RogersSJ, TrossS, Doingo-IngersolJ. Partner notification with HIV-infected drug users: results of formative research.AIDS Care1998; 10: 415-429
24.
Advisory Council on the Misuse of Drugs.The Primary Prevention of Hepatitis C Among Injecting Drug Users.London: Home Office, 2009
25.
MoutonM. ‘More than a liver’: social work's contribution to the well-being of people undergoing treatment for hepatitis C.J Soc Work Pract Addict2011; 11: 40-59
